Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  diethylstilbestrol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 37 for your search:
Start Over
Phase III DES vs TMX for Postmenopausal ER-Positive or ER-Unknown Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-79BRE334
Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-78-C-56, NCI-NMOB-814
Phase III Pelvic Irradiation vs Pelvic and Para-aortic Irradiation for Stage A2/B/C Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: RTOG-7506, RTOG-75-06
Phase III Randomized Adjuvant Chemotherapy with CTX/DES vs DES Alone Following Surgery or Radiotherapy for Stage A2/B/C Prostatic Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-81330
Phase III Randomized Comparison of DES/LEV vs DES Alone in Stage C/D Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-012-793, ICC-81U4
Phase III Orchiectomy or DES with or without CTX/5-FU for Stable Stage D Cancer of the Prostate
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NPCTG-1400
Phase III MEG vs MEG/DES vs Stilphostrol vs STZ for Previously Irradiated Hormone-Refractory Metastatic Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NPCTG-1600
Phase III Combined vs Sequential ADR/CTX and Orchiectomy or DES for Stage D or Refractory Adenocarcinoma of the Prostate (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8219
Phase III Randomized Comparison of Flutamide vs DES in Previously Untreated Patients with Stage D2 Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-5883
Phase III Randomized Comparison of DES vs Nafarelin in Patients with Stage D2 Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-304
Phase III Randomized Comparison of Hormonal Therapy with Flutamide vs DES in Previously Untreated Patients with Stage D2 Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RUSH-C83-06306, NCI-V85-0003
Phase III Randomized Study of Zoladex Depot vs Diethylstilbestrol in Patients with Stage D2 Prostate Carcinoma Who Have Refused Orchiectomy
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: AECM-8508171, NCI-V86-0028
Phase III Hormonal Therapy with Zoladex Depot vs Diethylstilbestrol in Patients with Stage D2 Prostate Carcinoma Who Have Refused Orchiectomy
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: WCCC-CO-8583, NCI-V86-0038
Phase III Hormonal Therapy with Zoladex Depot vs Diethylstilbestrol in Patients with Stage D2 Prostate Carcinoma Who Have Refused Orchiectomy
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: DCH-ZOL-56382, NCI-V86-0159
Phase III Randomized Comparison of DES vs Nafarelin in Patients with Stage D2 Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAOP-4186, NCI-V87-0186
Phase II Megestrol Acetate vs Diethylstilbestrol Adjuvant to Radiotherapy for Locally Advanced Stage B/C Carcinoma of the Prostate
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: RTOG-8307
Phase II Sequential vs Concurrent Cyclophosphamide and Diethylstilbestrol for Metastatic Prostatic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-78PR342, SEG-78PR0103
Phase II Nonrandomized Hormonal Therapy with DES and MEG in Patients with Advanced Adenocarcinoma of the Prostate
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NYU-8518, NCI-V86-0022
Phase II Randomized Study of IPP in Women with Metastatic Breast Cancer (Summary Last Modified 05/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-873252, MAYO-873252, NCCTG-87-32-52
Phase II Pilot Study of Neoadjuvant DES and Radical Prostatectomy in Patients with Stage B2/C Prostate Cancer (Summary Last Modified 06/90)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 40 and over
Sponsor:
Protocol IDs: MSKCC-89100, NCI-V89-0223
Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 83
Sponsor: Other
Protocol IDs: 02-4599-V, FHCRC-UW-02-4599-V, NCT00136526
Start Over